Michael Okunewitch

Stock Analyst at Maxim Group

(0)
# 4957
Out of 5,370 analysts
28
Total ratings
31.82%
Success rate
-24.98%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
HCWB HCW Biologics
Maintains: Buy
120 35
5.28 562.88% 2 May 29, 2025
CTOR Citius Oncology
Downgrades: Hold
n/a
n/a n/a 2 May 23, 2025
ANEB Anebulo Pharmaceutic...
Maintains: Buy
6 3
1.52 97.37% 2 May 15, 2025
RADX Radiopharm Theranost...
Initiates Coverage On: Buy
12
5.12 134.38% 1 May 1, 2025
CMMB Chemomab Therapeutic...
Maintains: Strong Buy
4 7
1.23 469.11% 2 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
1.62 764.2% 1 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
0.85 252.94% 1 Jan 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
1.15 247.83% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
0.79 1418.99% 1 Sep 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 6
1.3 361.54% 2 Aug 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 12
1.03 1065.05% 2 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2
n/a n/a 1 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
24
1.22 1867.21% 1 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
108 18
3.02 496.03% 3 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
2025
n/a n/a 1 Apr 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
20.58 21.48% 1 Dec 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
1.63 268.1% 1 Sep 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Feb 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
2.23 1021.08% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
100
0.77 12887.01% 1 Nov 30, 2021